Galaxy Biomedical Investment Co.Ltd(000806) : the reply of ZTE caiguanghua Certified Public Accountants (special general partnership) to the letter of concern about Galaxy Biomedical Investment Co.Ltd(000806) shows that after the second Department of listed company management of Shenzhen Stock Exchange Galaxy Biomedical Investment Co.Ltd(000806) (hereinafter referred to as “the company”) received your letter of concern about Galaxy Biomedical Investment Co.Ltd(000806) (company department concern letter [2021] No. 481) on December 29, ZTE caiguanghua Certified Public Accountants (special general partnership) (hereinafter referred to as the “audit institution”) has carefully analyzed the questions raised together with relevant departments of the company, and the relevant replies are as follows: 2. The name, time and date of occurrence of the supplier corresponding to the total 29 million yuan of accounts receivable of your company and its holding subsidiaries Jiang substation and liute substation Specific account title, amount, aging, procurement content, etc., and explain whether there is an association relationship between the supplier and your company’s controlling shareholders, persons acting in concert, directors, supervisors and senior managers. Ask the accountant to check the relevant contracts and express clear opinions on the authenticity of the relevant transactions and the accuracy of the amount
© China Stock Market News